Etelcalcetide: CE Certification and Safety Standards Compliance

We are pleased to present Etelcalcetide, a cutting-edge pharmaceutical product developed by Hybio Pharmaceutical Co., Ltd. This innovative medication has received the prestigious CE Certification, ensuring that it meets the highest quality and safety standards for medical devices in the European Union, This breakthrough medication offers healthcare professionals and patients a new and effective option for the management of secondary hyperparathyroidism, addressing a significant unmet medical need in this patient population. With the CE Certification, healthcare providers can have confidence in the quality, safety, and efficacy of Etelcalcetide, ultimately leading to better outcomes for patients, Hybio Pharmaceutical Co., Ltd. is committed to advancing healthcare through research and innovation, and Etelcalcetide is a prime example of our dedication to improving patient care